SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Analyst Earnings Estimates
FRA:56S1 - Deutsche Boerse Ag - FR0013154002 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.493B 20.98% | 2.776B -20.53% | 2.78B 0.16% | 3.06B 10.07% | 3.413B 11.54% | 3.806B 11.51% | 4.244B 11.51% | 5.016B 18.19% | 5.618B 12.00% | 6.293B 12.01% | 7.048B 12.00% | |
| EBITDA YoY % growth | 1.264B 23.41% | 707.9M -44.01% | 699.4M -1.20% | 887.54M 26.90% | 1.043B 17.52% | 1.207B 15.72% | 1.362B 12.84% | 1.725B 26.65% | 1.872B 8.52% | 2.031B 8.49% | N/A | |
| EBIT YoY % growth | 1.083B 22.62% | 470.3M -56.56% | 397.7M -15.44% | 601.3M 51.19% | 732.37M 21.80% | 849.18M 15.95% | 1.096B 29.07% | 1.489B 35.86% | 1.623B 9.00% | 1.77B 9.06% | N/A | |
| Operating Margin | 31.00% | 16.94% | 14.31% | 19.65% | 21.46% | 22.31% | 25.82% | 29.69% | 28.89% | 28.13% | N/A | |
| EPS YoY % growth | 8.64 15.82% | 4.19 -51.50% | 3.50 -16.47% | 4.34 24.02% | 5.46 25.89% | 6.72 22.99% | 8.15 21.29% | 9.53 16.90% | 11.17 17.24% | 13.06 16.87% | 14.64 12.10% |
All data in EUR
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.92 6.81% | 1.05 23.40% | 1.01 33.16% | 1.18 14.53% |
| Revenue Q2Q % growth | 718.32M 7.71% | 767.45M 8.64% | 728.72M 11.19% | 835.65M 11.23% |
| EBITDA Q2Q % growth | 209.39M 16.07% | 226.87M -9.00% | 219.55M -24.79% | 252.99M -34.58% |
| EBIT Q2Q % growth | 140.1M 27.36% | 156.22M 49.64% | 149.76M 111.53% | 171.8M 102.12% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 1.03 43.06% | 0.96 | 0.07 | 7.63% |
| Q3 2024 Q2Q % growth | 0.76 -10.59% | 0.81 | -0.05 | -5.62% |
| Q2 2024 Q2Q % growth | 0.85 -28.57% | 1.07 | -0.22 | -20.27% |
| Q1 2024 Q2Q % growth | 0.86 -39.86% | 0.95 | -0.09 | -9.42% |
| Q4 2023 Q2Q % growth | 0.72 -65.05% | 0.85 | -0.13 | -15.13% |
| Q3 2023 Q2Q % growth | 0.85 -61.01% | 2.81 | -1.96 | -69.78% |
| Q2 2023 Q2Q % growth | 1.19 -45.66% | 2.15 | -0.96 | -44.76% |
| Q1 2023 Q2Q % growth | 1.43 -35.29% | 1.44 | -0.01 | -0.76% |
| Q4 2022 Q2Q % growth | 2.06 6.19% | 2.17 | -0.11 | -5.05% |
| Q3 2022 Q2Q % growth | 2.18 7.39% | 3.05 | -0.87 | -28.54% |
| Q2 2022 Q2Q % growth | 2.19 18.38% | 3.27 | -1.08 | -33.08% |
| Q1 2022 Q2Q % growth | 2.21 34.76% | 2.79 | -0.58 | -20.84% |
| Q4 2021 Q2Q % growth | 1.94 70.18% | 1.83 | 0.11 | 5.83% |
| Q3 2021 Q2Q % growth | 2.03 69.17% | 1.85 | 0.18 | 9.83% |
| Q2 2021 Q2Q % growth | 1.85 94.74% | 1.57 | 0.28 | 18.17% |
| Q1 2021 Q2Q % growth | 1.64 88.51% | 1.46 | 0.18 | 11.98% |
| Q4 2020 Q2Q % growth | 1.14 62.86% | 1.09 | 0.05 | 4.70% |
| Q3 2020 Q2Q % growth | 1.20 64.38% | 0.95 | 0.25 | 25.73% |
| Q2 2020 Q2Q % growth | 0.95 28.38% | 0.91 | 0.04 | 4.28% |
| Q1 2020 Q2Q % growth | 0.87 27.94% | 0.77 | 0.10 | 13.71% |
| Q4 2019 Q2Q % growth | 0.70 | 0.71 | -0.01 | -1.20% |
| Q3 2019 Q2Q % growth | 0.73 | 0.70 | 0.03 | 4.98% |
| Q2 2019 Q2Q % growth | 0.74 | 0.68 | 0.06 | 9.60% |
| Q1 2019 Q2Q % growth | 0.68 | 0.61 | 0.07 | 11.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 751.3M 6.30% | 730.06M | 21.24M | 2.91% |
| Q3 2024 Q2Q % growth | 655.4M -1.72% | 690.73M | -35.33M | -5.11% |
| Q2 2024 Q2Q % growth | 706.4M 4.54% | 696.1M | 10.3M | 1.48% |
| Q1 2024 Q2Q % growth | 666.9M -8.15% | 726.14M | -59.24M | -8.16% |
| Q4 2023 Q2Q % growth | 706.8M -20.58% | 659.45M | 47.35M | 7.18% |
| Q3 2023 Q2Q % growth | 666.9M -24.08% | 723.67M | -56.77M | -7.84% |
| Q2 2023 Q2Q % growth | 675.7M -21.59% | 709.53M | -33.83M | -4.77% |
| Q1 2023 Q2Q % growth | 726.1M -15.81% | 733.36M | -7.26M | -0.99% |
| Q4 2022 Q2Q % growth | 890M 14.37% | 917.58M | -27.58M | -3.01% |
| Q3 2022 Q2Q % growth | 878.4M -58.35% | 906.82M | -28.42M | -3.13% |
| Q2 2022 Q2Q % growth | 861.8M 23.70% | 883.44M | -21.64M | -2.45% |
| Q1 2022 Q2Q % growth | 862.5M 31.64% | 787.82M | 74.68M | 9.48% |
| Q4 2021 Q2Q % growth | 778.177M 46.64% | 755.82M | 22.357M | 2.96% |
| Q3 2021 Q2Q % growth | 2.109B 313.17% | 703.67M | 1.405B | 199.69% |
| Q2 2021 Q2Q % growth | 696.7M 55.86% | 670.5M | 26.2M | 3.91% |
| Q1 2021 Q2Q % growth | 655.2M 55.22% | 584.79M | 70.41M | 12.04% |
| Q4 2020 Q2Q % growth | 530.681M 45.84% | 490.04M | 40.641M | 8.29% |
| Q3 2020 Q2Q % growth | 510.4M 38.92% | 456.85M | 53.55M | 11.72% |
| Q2 2020 Q2Q % growth | 447M 22.00% | 454.6M | -7.6M | -1.67% |
| Q1 2020 Q2Q % growth | 422.1M 23.10% | 403.42M | 18.68M | 4.63% |
| Q4 2019 Q2Q % growth | 363.87M | 365.92M | -2.05M | -0.56% |
| Q3 2019 Q2Q % growth | 367.4M | 349.18M | 18.22M | 5.22% |
| Q2 2019 Q2Q % growth | 366.4M | 339.5M | 26.9M | 7.92% |
| Q1 2019 Q2Q % growth | 342.9M | 319.94M | 22.96M | 7.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 12.28% | 1.27% | -0.23% |
| Revenue | 0% | 0.21% | 1.16% | 0.76% |